(Q35078764)

6 August 2017

1 reference

title

Anabolic agents and bone quality (English)

1 reference

6 August 2017

Tarek Sibai

1

1 reference

6 August 2017

Elise F Morgan

series ordinal

2

1 reference

6 August 2017

Thomas A Einhorn

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

Clinical Orthopaedics and Related Research

6 August 2017

published in

1 reference

6 August 2017

volume

469

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

2215-2224

1 reference

Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Transdermal lovastatin enhances fracture repair in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Growth hormone, insulin-like growth factors, and the skeleton

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Mechanisms of anabolic therapies for osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Prostaglandin E(2) receptors in bone formation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Strontium ranelate: a physiological approach for optimizing bone formation and resorption

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Bone turnover mediates preferential localization of prostate cancer in the skeleton.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Bone quality: where do we go from here?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Stimulation of bone formation in vitro and in rodents by statins

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Stemming bone loss by suppressing apoptosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

The in vivo anabolic actions of prostaglandins in bone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Protein prenylation: molecular mechanisms and functional consequences

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Anabolic actions of parathyroid hormone on bone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3126945

Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

The correction of BMD measurements for bone strontium content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Bone quality: getting closer to a definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Statin given perorally to adult rats increases cancellous bone mass and compressive strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Simvastatin improves fracture healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-010-1722-9

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

21 January 2018

1 reference

12 December 2020

Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy

1 reference

12 December 2020

A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats

1 reference

12 December 2020

Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations

1 reference

12 December 2020

Effect of simvastatin on fracture healing--an experimental study

1 reference

12 December 2020

Locally delivered lovastatin nanoparticles enhance fracture healing in rats

1 reference

12 December 2020

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

1 reference

12 December 2020

Parathyroid hormone enhances fracture healing. A preliminary report

1 reference

12 December 2020

Oral statins and increased bone-mineral density in postmenopausal women

1 reference

12 December 2020

Increased bone growth by local prostaglandin E2 in rats

1 reference

12 December 2020

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

12 December 2020

Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women

1 reference

12 December 2020

Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats

1 reference

12 December 2020

Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia

1 reference

12 December 2020

The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype

1 reference

12 December 2020

Anabolic Actions of Parathyroid Hormone on Bone*

1 reference

12 December 2020

10.1007/S11999-010-1722-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference